Skip to main content

Table 2 Comparison of survival rates of the two groups

From: Concurrent three-dimensional conformal radiotherapy and chemotherapy for postoperative recurrence of mediastinal lymph node metastases in patients with esophageal squamous cell carcinoma: a phase 2 single-institution study

 

1-year SR (%)

3-year SR (%)

5-year SR (%)

MS (Mo; 95% CI)

Group A

69.4

28.6

8.2

19 (14; 26)

Group B

85.7

46.9

14.3

35 (30; 40)

χ 2

4.602

4.298

3.798

 

P

0.032

0.038

0.051

 
  1. SR survival rate, MS median survival, Mo months.
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us